PARP trapping is governed by the PARP inhibitor dissociation rate constant

Cell Chem Biol. 2024 Jan 20:S2451-9456(23)00476-2. doi: 10.1016/j.chembiol.2023.12.019. Online ahead of print.

Abstract

Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) are a class of cancer drugs that enzymatically inhibit PARP activity at sites of DNA damage. Yet, PARPi function mainly by trapping PARP1 onto DNA with a wide range of potency among the clinically relevant inhibitors. How PARPi trap and why some are better trappers remain unknown. Here, we show trapping occurs primarily through a kinetic phenomenon at sites of DNA damage that correlates with PARPi koff. Our results suggest PARP trapping is not the physical stalling of PARP1 on DNA, rather the high probability of PARP re-binding damaged DNA in the absence of other DNA-binding protein recruitment. These results clarify how PARPi trap, shed new light on how PARPi function, and describe how PARPi properties correlate to trapping potency.

Keywords: DNA damage repair; PARP; PARP inhibitor; PARP trapping; PARP1; dissociation rate; protein recruitment.